Heranba Industries Targets ₹2,500 Crore Revenue This FY From Crop Protection And Nutrition Segments
Heranba Industries has launched two innovative crop nutrition products, Fentaamine and MycoHil, developed in collaboration with a leading American multinational company. The company targets ₹2,500 crore revenue this fiscal year from its combined crop protection and crop nutrition segments, aligning with its Vision 2026 growth roadmap for global expansion across 80+ countries.

*this image is generated using AI for illustrative purposes only.
Heranba Industries Limited has launched two innovative crop nutrition products, Fentaamine and MycoHil, marking its strategic entry into the rapidly expanding crop nutrition segment. The company announced ambitious revenue targets of ₹2,500 crore for the current fiscal year from its combined crop protection and crop nutrition segments.
Product Launch Details
The company introduced these breakthrough products at a grand launch event held at Leonia Holistic Destination in Hyderabad. Both products fall under the category of innovative crop nutrition solutions and are initially targeted at the domestic market.
| Parameter: | Details |
|---|---|
| Product Names: | Fentaamine and MycoHil |
| Category: | Innovative Crop Nutrition Solutions |
| Target Market: | Domestic |
| Development Partner: | Leading American multinational company |
| Revenue Target: | ₹2,500 crore this fiscal year |
Product Specifications and Benefits
Fentaamine is positioned as a next-generation bio stimulant engineered to enhance plant metabolism, improve stress tolerance, and boost crop yield. The product focuses on optimizing plant physiological processes to deliver improved agricultural outcomes.
MycoHil serves as an advanced biofertilizer designed to improve nutrient absorption, strengthen soil microbiology, and promote sustainable agriculture practices. This product emphasizes soil health enhancement and sustainable farming methodologies.
Both products have been developed through collaboration with a leading American multinational company, combining global research expertise with Heranba Industries' robust manufacturing capabilities.
Strategic Vision and Growth Targets
The company's entry into crop nutrition aligns with its Vision 2026 growth roadmap. Managing Director R. K. Shetty highlighted that the crop nutrition segment is witnessing strong growth with a CAGR of over 15% globally and in India, making it a natural strategic progression for the company.
| Vision 2026 Component: | Target |
|---|---|
| Revenue Target: | ₹2,500 crore in current fiscal year |
| Global Expansion: | 80+ countries |
| Regional Strategy: | Dubai subsidiary for Middle East and Africa |
| Manufacturing: | Seven world-class facilities and CMO operations |
Capability Enhancement Initiatives
To support its expansion strategy, Heranba Industries Limited is investing in multiple areas including talent acquisition and capability building, strengthening sales and marketing infrastructure, enhancing last-mile farmer engagement, channel partners engagement, and expanding global business operations.
The company operates as a leading manufacturer of synthetic pyrethroids and intermediates with a strong presence across the agrochemical value chain, from technicals to formulations. This latest product launch represents a significant milestone in the company's commitment to improving crop productivity and supporting global food security through innovative agricultural solutions.
Historical Stock Returns for Heranba Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.38% | -2.46% | +25.36% | -25.36% | -16.78% | -69.32% |
How will Heranba Industries compete against established players in India's crop nutrition market to achieve its ambitious ₹2,500 crore revenue target?
What impact could the company's expansion into 80+ countries have on global agrochemical market dynamics and competition?
Will Heranba Industries consider acquiring other crop nutrition companies or technologies to accelerate its Vision 2026 growth strategy?


































